Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVER-prevention: Chlorthalidone + Amiloride for Prevention of Hypertension
NCT00970931Phase 3Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jul 2010
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chlorthalidone, amiloride in hypertension (HTN), sponsored by Hospital de Clínicas de Porto Alegre. Started Jul 2010; status: completed.
02
Drugs
chlorthalidoneamiloride
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00970931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970931.